Abstracts from the NCRI Cancer Conference

Menu

Skip to content
  • Home
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021

Clinical Trials Showcase

PET-NECK: A multi-centre, randomised, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT)

CheckMate 067: a phase III randomised double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy treatment-naïve patients (pts) with advanced melanoma (MEL)

Docetaxel and/or zoledronic acid for hormone-naïve prostate cancer: First overall survival results from STAMPEDE(NCT00268476)

A phase II/III randomised trial comparing maintenance lapatinib vs placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer

  • Search 2015 Abstracts

  • 2015 Abstract Navigation

    • Poster session A (Monday)
    • Poster session B (Tuesday)
    • 2015 Plenary speakers
    • 2015 Symposia
    • 2015 Parallel sessions
    • Clinical Trials Showcase
    • Proffered Paper Sessions